Selecting Patients for Activa Parkinson’s Control Therapy

General Considerations for Patient Selection

• The patient must be an appropriate candidate for stereotactic procedures. The patient must be physically able to undergo the surgical procedure, and must be able to cooperate by answering questions and following directions during the surgery.
• Patients with significant cognitive decline or dementia are not typically considered for Activa Therapy implant surgery.
• The patient must understand the nature of the therapy and be able to operate the neurostimulator Control Magnet or Therapy Controller.
• The patient must be available for periodic follow-up visits.
  

Use in Specific Populations

The safety and effectiveness of this therapy has not been established for patients with the following:

• Neurological disease origins other than idiopathic Parkinson’s disease
• Previous surgical ablation procedure
• Pregnancy
• Dementia
• Coagulopathies
• Moderate to severe depression
• Patients under the age of 18 years
• Patients over the age of 75 years

Refer to the Activa Therapy Clinical Summary for more detailed information.

©Medtronic, Inc. 2008                                                   • Contact Medtronic • Privacy Statement • Terms of Use • Site Map